Loading clinical trials...
Loading clinical trials...
MRI Allocation of Pacing Targets in Cardiac Resynchronization Therapy
This randomized controlled trial will assess a cardiac MRI derived 4D digital cardiac model to optimized left and right ventricular lead delivery to improve response to cardiac resynchronization therapy.
Regional mechanical delay, myocardial scar, and inter-lead distance have each been demonstrated to be relevant variables for the realization of optimal response to cardiac resynchronization therapy (CRT). Pilot study results have suggested clinical feasibility and potential value from LV and RV lead navigation aimed at optimizing these combined variables. A computer software program has been developed to deliver an interactive, 4D digital heart model of mechanical dyssynchrony and myocardial scar to guide LV and RV CRT lead delivery to optimal targets. This multi-center randomized clinical trial has been designed to assess the feasibility, safety and clinical impact of LV-RV lead navigation using a web-deployed 4D cardiac model.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Conect Research, University of Calgary
Calgary, Alberta, Canada
Halifax Capital Districy Health Authority
Halifax, Nova Scotia, Canada
Libin Cardiovascular Institute
London, Ontario, Canada
Ottawa Heart Institute Research Corporation
Ottawa, Ontario, Canada
University of Laval Research Centre
Québec, Quebec, Canada
Start Date
September 1, 2014
Primary Completion Date
January 1, 2022
Completion Date
January 1, 2023
Last Updated
June 25, 2025
210
ACTUAL participants
4D Model guided delivery of cardiac pacing leads
PROCEDURE
Standard CRT lead delivery
PROCEDURE
Lead Sponsor
Libin Cardiovascular Institute of Alberta
Collaborators
NCT03984591
NCT04065893
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02026102